DSM-Firmenich (DSFIR.AS) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $26.16B | Exchange | AMS |
| Sector | Consumer Defensive | Industry | Household & Personal Products |
| Country | CH | CEO | Dimitri de Vreeze |
| IPO Date | 2023-05-09 | CAGR | 0.16% |
| Employees | 28,550 | Website | www.dsm-firmenich.com |
| Div. Yield | 4.36% | Payout Ratio | -119% |
| Buy Back Yield | 10.37% | Total Yield | 14.73% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $28.53B | P/E | 16.22 | Forward P/E | 22.36 | PEG | -1.16 |
| P/S | 1.35 | P/B | 0.83 | P/CF | 7.7 | P/FCF | 22.22 |
| Sales | $12.04B | Sales 1Y | -19.08% | Sales 3Y | -19.86% | Sales 5Y | 37.93% |
| EPS | $6.53 | EPS 1Y | -333.98% | EPS 3Y | -397.22% | EPS 5Y | -97.67% |
| Sales QoQ | 84.79% | EPS QoQ | -113.93% | Sales QoQ Avg | — | EPS QoQ Avg | — |
| Gross Margin | 40.7% | Operating Margin | 7.01% | Profit Margin | -10.76% | ROCE | 2.96% |
| ROA | -4% | ROE | -6% | Altman Z Score | 2.08 | Piotroski Score | 5 |
| Current Ratio | 1.75 | Quick Ratio | 1.36 | Cash Ratio | 0.4 | Op. CF Ratio | 0.08 |
| Debt/Equity | 0.38 | Debt/Assets | 0.22 | Lt Debt/Equity | 0.29 | Lt Debt/Cap. | 0.22 |
| Intrst Cov. | 3.72 | Inventory Turnover | 2.8 | Asset Turnover | 0.34 | Receivables Turnover | 4.43 |
| Enterprise Value | $28.53B | P/E Ratio | 16.22 |
| Forward P/E | 22.36 | PEG Ratio | -1.16 |
| P/S Ratio | 1.35 | P/B Ratio | 0.83 |
| P/CF Ratio | 7.7 | P/FCF Ratio | 22.22 |
| EPS | $6.53 | EPS Growth 1Y | -333.98% |
| EPS Growth 3Y | -397.22% | EPS Growth 5Y | -97.67% |
| Revenue Growth 1Y | -19.08% | Gross Margin | 0.41% |
| Operating Margin | 0.07% | Profit Margin | -0.11% |
| ROE | -0.06% | ROA | -0.04% |
| ROCE | 0.03% | Current Ratio | 1.75 |
| Quick Ratio | 1.36 | Cash Ratio | 0.4 |
| Debt/Equity | 0.38 | Interest Coverage | 3.72 |
| Altman Z Score | 2.08 | Piotroski Score | 5 |
DSM-Firmenich (DSFIR.AS) valuation & financials
DSM-Firmenich (DSFIR.AS) has a market capitalization of 26.16B EUR and trades at a price-to-earnings ratio of 16.2. It operates in the Consumer Defensive sector (Household & Personal Products).
DSM-Firmenich's revenue grew -19.1% over the last year.
DSM-Firmenich's next earnings report is scheduled for February 18, 2027; analysts estimate EPS of 1.99 EUR. Check the earnings calendar to see all companies reporting this week.
DSM-Firmenich (DSFIR.AS) — frequently asked questions
When does DSM-Firmenich (DSFIR.AS) report earnings next?
DSM-Firmenich is expected to report earnings on February 18, 2027. Analysts estimate EPS of 1.99 EUR.
What is DSM-Firmenich's market cap?
DSM-Firmenich (DSFIR.AS) has a market capitalization of 26.16B EUR.
What is DSFIR.AS's P/E ratio?
DSM-Firmenich trades at a price-to-earnings ratio of 16.2, with trailing twelve-month EPS of 6.53 EUR.
How fast is DSM-Firmenich growing?
DSM-Firmenich's revenue grew -19.1% over the last year.
Compare with other Consumer Defensive companies: Walmart (WMT) · Costco (COST) · Coca-Cola (KO) · Procter & Gamble (PG) · Philip Morris (PM) · Nestlé (NESN.SW)